Finance ❯ Investing ❯ Stock Market ❯ Market Trends

Company Stocks

Roche’s Oral BTK Drug Succeeds in Phase 3 MS Trials, Matching Ocrevus in Progressive Disease

Full relapsing data remain pending until a second trial reports in 2026.

Quantum Stocks Swing as U.S. Denies Equity Talks and Nvidia Touts GPU–Quantum Links